Journal article icon

Journal article

Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation

Abstract:

Treatment of tumors with ionizing radiation stimulates an antitumor immune response partly dependent on induction of IFNs. These IFNs directly enhance dendritic cell and CD8+ T cell activity. Here we show that resistance to an effective antitumor immune response is also a result of IFN signaling in a different cellular compartment of the tumor, the cancer cells themselves. We abolished type I IFN signaling in cancer cells by genetic elimination of its receptor, IFNAR1. Pronounced immune respo...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1172/JCI127458

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst for Radiation Oncology
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst for Radiation Oncology
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst for Radiation Oncology
ORCID:
0000-0002-8674-702X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst for Radiation Oncology
ORCID:
0000-0001-5973-0049
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst for Radiation Oncology
Expand authors...
Publisher:
American Society for Clinical Investigation Publisher's website
Journal:
Journal of Clinical Investigation Journal website
Volume:
129
Issue:
10
Pages:
4224-4238
Publication date:
2019-10-01
Acceptance date:
2019-07-03
DOI:
EISSN:
1558-8238
ISSN:
0021-9738
Pmid:
31483286
Pubs id:
1049655
Local pid:
pubs:1049655
Language:
English
Keywords:
Format:
Print

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP